Atherosclerotic Plaque Rupture: Identifying the Straw That Breaks the Camel?s Back

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 8, 2016, Pages e63-e72

  Chen, Yung Chih ^a   Huang, Alex L ^a,b   Kyaw, Tin S ^a   Bobik, Alex ^a,b   Peter, Karlheinz ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

atherosclerosis; atherosclerotic plaque; biomarkers; C reactive protein; interleukins

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; LIPID;

ARTICLE; ATHEROSCLEROTIC PLAQUE; HEMODYNAMICS; HUMAN; LYMPHOCYTE; LYMPHOID ORGAN; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; ANIMAL; ATHEROSCLEROSIS; BLEEDING; BLOOD; DISEASE MODEL; LYMPHOID TISSUE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RUPTURE; VASCULARIZATION;

ANIMALS; ATHEROSCLEROSIS; BIOMARKERS; BLOOD PLATELETS; DISEASE MODELS, ANIMAL; HEMODYNAMICS; HEMORRHAGE; HUMANS; LIPIDS; LYMPHOCYTES; LYMPHOID TISSUE; MACROPHAGES; MONOCYTES; PLAQUE, ATHEROSCLEROTIC; RUPTURE, SPONTANEOUS;

EID: 84979882453     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.116.307993     Document Type: Article

References (127)

1. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20:1262-1275
2. Peeters W, Hellings WE, de Kleijn DP, de Vries JP, Moll FL, Vink A, Pasterkamp G. Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilization. Arterioscler Thromb Vasc Biol. 2009;29:128-133. doi: 10. 1161/ ATVBAHA. 108. 173658
3. Chen YC, Peter K. Determining the characteristics of human atherosclerosis: A difficult but indispensable task providing the direction and proof of concept for pioneering atherosclerosis research in animal models. Atherosclerosis. 2015;241:595-596. doi: 10. 1016/j. atherosclerosis. 2015. 06. 009
4. Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R. Concept of vulnerable/ unstable plaque. Arterioscler Thromb Vasc Biol. 2010;30:1282-1292. doi: 10. 1161/ATVBAHA. 108. 179739
5. Hansson GK, Libby P, Tabas I. Inflammation and plaque vulnerability. J Intern Med. 2015;278:483-493. doi: 10. 1111/joim. 12406
6. Kolodgie FD, Burke AP, Farb A, Gold HK, Yuan J, Narula J, Finn AV, Virmani R. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol. 2001;16:285-292
7. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation. 2003;108:1772-1778. doi: 10. 1161/01. CIR. 0000087481. 55887. C9
8. Burke AP, Kolodgie FD, Farb A, Weber DK, Malcom GT, Smialek J, Virmani R. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation. 2001;103:934-940
9. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, Mehran R, McPherson J, Farhat N, Marso SP, Parise H, Templin B, White R, Zhang Z, Serruys PW; PROSPECT Investigators. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364:226-235. doi: 10. 1056/NEJMoa1002358
10. Puri R, Madder RD, Madden SP, et al. Near-Infrared Spectroscopy Enhances Intravascular Ultrasound Assessment of Vulnerable Coronary Plaque: A Combined Pathological and In Vivo Study. Arterioscler Thromb Vasc Biol. 2015;35:2423-2431. doi: 10. 1161/ATVBAHA. 115. 306118
11. Madder RD, Puri R, Muller JE, Harnek J, Götberg M, VanOosterhout S, Chi M, Wohns D, McNamara R, Wolski K, Madden S, Sidharta S, Andrews J, Nicholls SJ, Erlinge D. Confirmation of the intracoronary near-infrared spectroscopy threshold of lipid-rich plaques that underlie ST-segment-elevation myocardial infarction. Arterioscler Thromb Vasc Biol. 2016;36:1010-1015. doi: 10. 1161/ATVBAHA. 115. 306849
12. Pedersen SF, Sandholt BV, Keller SH, Hansen AE, Clemmensen AE, Sillesen H, Højgaard L, Ripa RS, Kjær A. 64Cu-DOTATATE PET/MRI for Detection of activated macrophages in carotid atherosclerotic plaques: studies in patients undergoing endarterectomy. Arterioscler Thromb Vasc Biol. 2015;35:1696-1703. doi: 10. 1161/ATVBAHA. 114. 305067
13. von zur Muhlen C, von Elverfeldt D, Moeller JA, Choudhury RP, Paul D, Hagemeyer CE, Olschewski M, Becker A, Neudorfer I, Bassler N, Schwarz M, Bode C, Peter K. Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis. Circulation. 2008;118:258-267. doi: 10. 1161/CIRCULATIONAHA. 107. 753657
14. Li X, Bauer W, Israel I, Kreissl MC, Weirather J, Richter D, Bauer E, Herold V, Jakob P, Buck A, Frantz S, Samnick S. Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo 17. 6T MRI. Arterioscler Thromb Vasc Biol. 2014;34:1661-1667. doi: 10. 1161/ ATVBAHA. 114. 303485
15. Joshi NV, Vesey AT, Williams MC, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet. 2014;383:705-713. doi: 10. 1016/S0140-6736(13)61754-7
16. Libby P, King K. Biomarkers: a challenging conundrum in cardiovascular disease. Arterioscler Thromb Vasc Biol. 2015;35:2491-2495. doi: 10. 1161/ATVBAHA. 115. 305233
17. Hlatky MA, Greenland P, Arnett DK, et al; American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Council. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009;119:2408-2416. doi: 10. 1161/ CIRCULATIONAHA. 109. 192278
18. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32:2045-2051. doi: 10. 1161/ATVBAHA. 108. 179705
19. Aubry MC, Maradit-Kremers H, Reinalda MS, Crowson CS, Edwards WD, Gabriel SE. Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol. 2007;34:937-942
20. Tattersall MC, Guo M, Korcarz CE, Gepner AD, Kaufman JD, Liu KJ, Barr RG, Donohue KM, McClelland RL, Delaney JA, Stein JH. Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35:1520-1525. doi: 10. 1161/ATVBAHA. 115. 305452
21. Schuett KA, Lehrke M, Marx N, Burgmaier M. High-risk cardiovascular patients: clinical features, comorbidities, and interconnecting mechanisms. Front Immunol. 2015;6:591. doi: 10. 3389/fimmu. 2015. 00591
22. Yousuf O, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, Nasir K, Blumenthal RS, Budoff MJ. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol. 2013;62:397-408. doi: 10. 1016/j. jacc. 2013. 05. 016
23. Durda P, Sabourin J, Lange EM, et al. Plasma levels of soluble interleukin-2 receptor α: associations with clinical cardiovascular events and genome-wide association scan. Arterioscler Thromb Vasc Biol. 2015;35:2246-2253. doi: 10. 1161/ATVBAHA. 115. 305289
24. Maiolino G, Rossitto G, Pedon L, Cesari M, Frigo AC, Azzolini M, Plebani M, Rossi GP. Galectin-3 predicts long-term cardiovascular death in high-risk patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2015;35:725-732. doi: 10. 1161/ATVBAHA. 114. 304964
25. Gasbarrino K, Mantzoros C, Gorgui J, Veinot JP, Lai C, Daskalopoulou SS. Circulating chemerin is associated with carotid plaque instability, whereas resistin is related to cerebrovascular symptomatology. Arterioscler Thromb Vasc Biol. 2016;36:1670-1678. doi: 10. 1161/ATVBAHA. 115. 306741
26. Goncalves I, Bengtsson E, Colhoun HM, et al; SUMMIT Consortium. Elevated plasma levels of MMP-12 are associated with atherosclerotic burden and symptomatic cardiovascular disease in subjects with type 2 diabetes. Arterioscler Thromb Vasc Biol. 2015;35:1723-1731. doi: 10. 1161/ATVBAHA. 115. 305631
27. Rattik S, Wigren M, Björkbacka H, Fredrikson GN, Hedblad B, Siegbahn A, Bengtsson E, Schiopu A, Edsfeldt A, Dunér P, Grufman H, Gonçalves I, Nilsson J. High plasma levels of heparin-binding epidermal growth factor are associated with a more stable plaque phenotype and reduced incidence of coronary events. Arterioscler Thromb Vasc Biol. 2015;35:222-228. doi: 10. 1161/ATVBAHA. 114. 304369
28. von Zur Muhlen C, Schiffer E, Zuerbig P, Kellmann M, Brasse M, Meert N, Vanholder RC, Dominiczak AF, Chen YC, Mischak H, Bode C, Peter K. Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients. J Proteome Res. 2009;8:335-345. doi: 10. 1021/pr800615t
29. Bye A, Røsjø H, Nauman J, Silva GJ, Follestad T, Omland T, Wisløff U. Circulating microRNAs predict future fatal myocardial infarction in healthy individuals-The HUNT study. J Mol Cell Cardiol. 2016;97:162-168. doi: 10. 1016/j. yjmcc. 2016. 05. 009
30. Warboys CM, de Luca A, Amini N, et al. Disturbed flow promotes endothelial senescence via a p53-dependent pathway. Arterioscler Thromb Vasc Biol. 2014;34:985-995. doi: 10. 1161/ATVBAHA. 114. 303415
31. Caro CG. Discovery of the role of wall shear in atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:158-161. doi: 10. 1161/ ATVBAHA. 108. 166736
32. Cheruvu PK, Finn AV, Gardner C, Caplan J, Goldstein J, Stone GW, Virmani R, Muller JE. Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study. J Am Coll Cardiol. 2007;50:940-949. doi: 10. 1016/j. jacc. 2007. 04. 086
33. Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol. 2007;49:2379-2393. doi: 10. 1016/j. jacc. 2007. 02. 059
34. Chatzizisis YS, Baker AB, Sukhova GK, Koskinas KC, Papafaklis MI, Beigel R, Jonas M, Coskun AU, Stone BV, Maynard C, Shi GP, Libby P, Feldman CL, Edelman ER, Stone PH. Augmented expression and activity of extracellular matrix-degrading enzymes in regions of low endothelial shear stress colocalize with coronary atheromata with thin fibrous caps in pigs. Circulation. 2011;123:621-630. doi: 10. 1161/ CIRCULATIONAHA. 110. 970038
35. Doddaballapur A, Michalik KM, Manavski Y, Lucas T, Houtkooper RH, You X, Chen W, Zeiher AM, Potente M, Dimmeler S, Boon RA. Laminar shear stress inhibits endothelial cell metabolism via KLF2-mediated repression of PFKFB3. Arterioscler Thromb Vasc Biol. 2015;35:137-145. doi: 10. 1161/ATVBAHA. 114. 304277
36. Cybulsky MI, Marsden PA. Effect of disturbed blood flow on endothelial cell gene expression: a role for changes in RNA processing. Arterioscler Thromb Vasc Biol. 2014;34:1806-1808. doi: 10. 1161/ ATVBAHA. 114. 304099
37. Jiang YZ, Manduchi E, Jiménez JM, Davies PF. Endothelial epigenetics in biomechanical stress: disturbed flow-mediated epigenomic plasticity in vivo and in vitro. Arterioscler Thromb Vasc Biol. 2015;35:1317-1326. doi: 10. 1161/ATVBAHA. 115. 303427
38. Dunn J, Thabet S, Jo H. Flow-Dependent epigenetic DNA methylation in endothelial gene expression and atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35:1562-1569. doi: 10. 1161/ATVBAHA. 115. 305042
39. Zhang X, Cheng R, Rowe D, Sethu P, Daugherty A, Yu G, Shin HY. Shear-sensitive regulation of neutrophil flow behavior and its potential impact on microvascular blood flow dysregulation in hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2014;34:587-593. doi: 10. 1161/ ATVBAHA. 113. 302868
40. Boulanger CM. Endothelium. Arterioscler Thromb Vasc Biol. 2016;36:e26-e31. doi: 10. 1161/ATVBAHA. 116. 306940
41. Abe J, Berk BC. Novel mechanisms of endothelial mechanotransduction. Arterioscler Thromb Vasc Biol. 2014;34:2378-2386. doi: 10. 1161/ ATVBAHA. 114. 303428
42. Bryan MT, Duckles H, Feng S, Hsiao ST, Kim HR, Serbanovic-Canic J, Evans PC. Mechanoresponsive networks controlling vascular inflammation. Arterioscler Thromb Vasc Biol. 2014;34:2199-2205. doi: 10. 1161/ ATVBAHA. 114. 303424
43. Murphy PA, Hynes RO. Alternative splicing of endothelial fibronectin is induced by disturbed hemodynamics and protects against hemorrhage of the vessel wall. Arterioscler Thromb Vasc Biol. 2014;34:2042-2050. doi: 10. 1161/ATVBAHA. 114. 303879
44. Zhou J, Li YS, Chien S. Shear stress-initiated signaling and its regulation of endothelial function. Arterioscler Thromb Vasc Biol. 2014;34:2191-2198. doi: 10. 1161/ATVBAHA. 114. 303422
45. Slager CJ, Wentzel JJ, Gijsen FJ, Thury A, van der Wal AC, Schaar JA, Serruys PW. The role of shear stress in the destabilization of vulnerable plaques and related therapeutic implications. Nat Clin Pract Cardiovasc Med. 2005;2:456-464. doi: 10. 1038/ncpcardio0298
46. Pedrigi RM, de Silva R, Bovens SM, Mehta VV, Petretto E, Krams R. Thin-cap fibroatheroma rupture is associated with a fine interplay of shear and wall stress. Arterioscler Thromb Vasc Biol. 2014;34:2224-2231. doi: 10. 1161/ATVBAHA. 114. 303426
47. Chen YC, Bui AV, Diesch J, Manasseh R, Hausding C, Rivera J, Haviv I, Agrotis A, Htun NM, Jowett J, Hagemeyer CE, Hannan RD, Bobik A, Peter K. A novel mouse model of atherosclerotic plaque instability for drug testing and mechanistic/therapeutic discoveries using gene and microRNA expression profiling. Circ Res. 2013;113:252-265. doi: 10. 1161/CIRCRESAHA. 113. 301562
48. Sasaki T, Kuzuya M, Nakamura K, Cheng XW, Shibata T, Sato K, Iguchi A. A simple method of plaque rupture induction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2006;26:1304-1309. doi: 10. 1161/01. ATV. 0000219687. 71607. f7
49. Williams H, Johnson JL, Carson KG, Jackson CL. Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2002;22:788-792
50. Hansson GK, Heistad DD. Two views on plaque rupture. Arterioscler Thromb Vasc Biol. 2007;27:697. doi: 10. 1161/01. ATV. 0000261344. 03489. 0c
51. Falk E, Schwartz SM, Galis ZS and Rosenfeld ME. Neointimal cracks (plaque rupture?) and thrombosis in wrapped arteries without flow. Arterioscler Thromb Vasc Biol. 2007;27:248-249; author reply 250-252
52. Jackson CL. Defining and defending murine models of plaque rupture. Arterioscler Thromb Vasc Biol. 2007;27:973-977. doi: 10. 1161/01. ATV. 0000261545. 53586. f0
53. Jin SX, Shen LH, Nie P, Yuan W, Hu LH, Li DD, Chen XJ, Zhang XK, He B. Endogenous renovascular hypertension combined with low shear stress induces plaque rupture in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2012;32:2372-2379. doi: 10. 1161/ ATVBAHA. 111. 236158
54. Li S, Wang YN, Niimi M, Ning B, Chen Y, Kang D, Waqar AB, Wang Z, Yu Q, Liu E, Zhang J, Shiomi M, Chen YE, Fan J. Angiotensin II destabilizes coronary plaques in watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol. 2016;36:810-816. doi: 10. 1161/ ATVBAHA. 115. 306871
55. Pasterkamp G, van der Laan SW, Haitjema S, et al. Human validation of genes associated with a murine atherosclerotic phenotype. Arterioscler Thromb Vasc Biol. 2016;36:1240-1246. doi: 10. 1161/ATVBAHA. 115. 306958
56. Schwartz SM, Galis ZS, Rosenfeld ME, Falk E. Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol. 2007;27:705-713. doi: 10. 1161/01. ATV. 0000261709. 34878. 20
57. Jackson CL, Bennett MR, Biessen EA, Johnson JL, Krams R. Assessment of unstable atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 2007;27:714-720. doi: 10. 1161/01. ATV. 0000261873. 86623. e1
58. Edsfeldt A, Dunér P, Ståhlman M, Mollet IG, Asciutto G, Grufman H, Nitulescu M, Persson AF, Fisher RM, Melander O, Orho-Melander M, Borén J, Nilsson J, Gonçalves I. Sphingolipids contribute to human atherosclerotic plaque inflammation. Arterioscler Thromb Vasc Biol. 2016;36:1132-1140. doi: 10. 1161/ATVBAHA. 116. 305675
59. Ronsein GE, Hutchins PM, Isquith D, Vaisar T, Zhao XQ, Heinecke JW. Niacin Therapy increases high-density lipoprotein particles and total cholesterol efflux capacity but not ABCA1-specific cholesterol efflux in statin-treated subjects. Arterioscler Thromb Vasc Biol. 2016;36:404-411. doi: 10. 1161/ATVBAHA. 115. 306268
60. Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K, McBride R, Teo K, Weintraub W; AIM-HIGH Investigators. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011;365:2255-2267. doi: 10. 1056/NEJMoa1107579
61. Melchior JT, Olson JD, Kelley KL, Wilson MD, Sawyer JK, Link KM, Rudel LL. Targeted knockdown of hepatic SOAT2 with antisense oligonucleotides stabilizes atherosclerotic plaque in ApoB100-only LDLr-/-mice. Arterioscler Thromb Vasc Biol. 2015;35:1920-1927. doi: 10. 1161/ ATVBAHA. 115. 305747
62. Doonan RJ, Hafiane A, Lai C, Veinot JP, Genest J, Daskalopoulou SS. Cholesterol efflux capacity, carotid atherosclerosis, and cerebrovascular symptomatology. Arterioscler Thromb Vasc Biol. 2014;34:921-926. doi: 10. 1161/ATVBAHA. 113. 302590
63. Moreno PR. Vulnerable plaque: definition, diagnosis, and treatment. Cardiol Clin. 2010;28:1-30. doi: 10. 1016/j. ccl. 2009. 09. 008
64. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003;108:1664-1672. doi: 10. 1161/01. CIR. 0000087480. 94275. 97
65. Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R. Update on acute coronary syndromes: the pathologists' view. Eur Heart J. 2013;34:719-728. doi: 10. 1093/eurheartj/ehs411
66. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, Wrenn SP, Narula J. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol. 2005;25:2054-2061. doi: 10. 1161/01. ATV. 0000178991. 71605. 18
67. Michel JB, Virmani R, Arbustini E, Pasterkamp G. Intraplaque haemorrhages as the trigger of plaque vulnerability. Eur Heart J. 2011;32:1977-1985, 1985a, 1985b, 1985c. doi: 10. 1093/eurheartj/ehr054
68. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, Farb A, Guerrero LJ, Hayase M, Kutys R, Narula J, Finn AV, Virmani R. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med. 2003;349:2316-2325. doi: 10. 1056/NEJMoa035655
69. Hellings WE, Peeters W, Moll FL, Piers SR, van Setten J, Van der Spek PJ, de Vries JP, Seldenrijk KA, De Bruin PC, Vink A, Velema E, de Kleijn DP, Pasterkamp G. Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study. Circulation. 2010;121:1941-1950. doi: 10. 1161/ CIRCULATIONAHA. 109. 887497
70. Di Stefano R, Felice F, Balbarini A. Angiogenesis as risk factor for plaque vulnerability. Curr Pharm Des. 2009;15:1095-1106
71. Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res. 2014;114:1852-1866. doi: 10. 1161/ CIRCRESAHA. 114. 302721
72. Li JJ, Meng X, Si HP, Zhang C, Lv HX, Zhao YX, Yang JM, Dong M, Zhang K, Liu SX, Zhao XQ, Gao F, Liu XL, Cui TX, Zhang Y. Hepcidin destabilizes atherosclerotic plaque via overactivating macrophages after erythrophagocytosis. Arterioscler Thromb Vasc Biol. 2012;32:1158-1166. doi: 10. 1161/ATVBAHA. 112. 246108
73. Saeed O, Otsuka F, Polavarapu R, et al. Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32:299-307. doi: 10. 1161/ATVBAHA. 111. 240101
74. Mehta NU, Grijalva V, Hama S, Wagner A, Navab M, Fogelman AM, Reddy ST. Apolipoprotein E-/-mice lacking hemopexin develop increased atherosclerosis via mechanisms that include oxidative stress and altered macrophage function. Arterioscler Thromb Vasc Biol. 2016;36:1152-1163. doi: 10. 1161/ATVBAHA. 115. 306991
75. Sun J, Canton G, Balu N, Hippe DS, Xu D, Liu J, Hatsukami TS, Yuan C. Blood pressure is a major modifiable risk factor implicated in pathogenesis of intraplaque hemorrhage: an In Vivo Magnetic Resonance Imaging Study. Arterioscler Thromb Vasc Biol. 2016;36:743-749. doi: 10. 1161/ ATVBAHA. 115. 307043
76. Selwaness M, van den Bouwhuijsen Q, Mattace-Raso FU, Verwoert GC, Hofman A, Franco OH, Witteman JC, van der Lugt A, Vernooij MW, Wentzel JJ. Arterial stiffness is associated with carotid intraplaque hemorrhage in the general population: the Rotterdam study. Arterioscler Thromb Vasc Biol. 2014;34:927-932. doi: 10. 1161/ ATVBAHA. 113. 302603
77. Massberg S, Brand K, Grüner S, Page S, Müller E, Müller I, Bergmeier W, Richter T, Lorenz M, Konrad I, Nieswandt B, Gawaz M. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med. 2002;196:887-896
78. Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med. 2003;9:61-67. doi: 10. 1038/nm810
79. Badrnya S, Schrottmaier WC, Kral JB, Yaiw KC, Volf I, Schabbauer G, Söderberg-Nauclér C, Assinger A. Platelets mediate oxidized low-density lipoprotein-induced monocyte extravasation and foam cell formation. Arterioscler Thromb Vasc Biol. 2014;34:571-580. doi: 10. 1161/ ATVBAHA. 113. 302919
80. Koupenova M, Mick E, Mikhalev E, Benjamin EJ, Tanriverdi K, Freedman JE. Sex differences in platelet toll-like receptors and their association with cardiovascular risk factors. Arterioscler Thromb Vasc Biol. 2015;35:1030-1037. doi: 10. 1161/ATVBAHA. 114. 304954
81. Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group. Circulation. 1997;96:2468-2482
82. Assinger A, Kral JB, Yaiw KC, Schrottmaier WC, Kurzejamska E, Wang Y, Mohammad AA, Religa P, Rahbar A, Schabbauer G, Butler LM, Söderberg-Naucler C. Human cytomegalovirus-platelet interaction triggers toll-like receptor 2-dependent proinflammatory and proangiogenic responses. Arterioscler Thromb Vasc Biol. 2014;34:801-809. doi: 10. 1161/ATVBAHA. 114. 303287
83. Rosenfeld ME, Campbell LA. Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thromb Haemost. 2011;106:858-867. doi: 10. 1160/TH11-06-0392
84. Ley K, Miller YI, Hedrick CC. Monocyte and macrophage dynamics during atherogenesis. Arterioscler Thromb Vasc Biol. 2011;31:1506-1516. doi: 10. 1161/ATVBAHA. 110. 221127
85. Huang Y, Yin H, Wang J, Ma X, Zhang Y, Chen K. The significant increase of FcγRIIIA (CD16), a sensitive marker, in patients with coronary heart disease. Gene. 2012;504:284-287. doi: 10. 1016/j. gene. 2012. 05. 017
86. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94:2493-2503. doi: 10. 1172/JCI117619
87. Vendrov AE, Hakim ZS, Madamanchi NR, Rojas M, Madamanchi C, Runge MS. Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells. Arterioscler Thromb Vasc Biol. 2007;27:2714-2721. doi: 10. 1161/ATVBAHA. 107. 152629
88. Combadière C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B, Merval R, Proudfoot A, Tedgui A, Mallat Z. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation. 2008;117:1649-1657. doi: 10. 1161/ CIRCULATIONAHA. 107. 745091
89. van der Vorst EP, Döring Y, Weber C. Chemokines. Arterioscler Thromb Vasc Biol. 2015;35:e52-e56. doi: 10. 1161/ATVBAHA. 115. 306359
90. Rogacev KS, Zawada AM, Emrich I, Seiler S, Böhm M, Fliser D, Woollard KJ, Heine GH. Lower Apo A-I and lower HDL-C levels are associated with higher intermediate CD14++CD16+ monocyte counts that predict cardiovascular events in chronic kidney disease. Arterioscler Thromb Vasc Biol. 2014;34:2120-2127. doi: 10. 1161/ ATVBAHA. 114. 304172
91. Rogacev KS, Cremers B, Zawada AM, et al. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. J Am Coll Cardiol. 2012;60:1512-1520. doi: 10. 1016/j. jacc. 2012. 07. 019
92. Kashiwagi M, Imanishi T, Tsujioka H, Ikejima H, Kuroi A, Ozaki Y, Ishibashi K, Komukai K, Tanimoto T, Ino Y, Kitabata H, Hirata K, Akasaka T. Association of monocyte subsets with vulnerability characteristics of coronary plaques as assessed by 64-slice multidetector computed tomography in patients with stable angina pectoris. Atherosclerosis. 2010;212:171-176. doi: 10. 1016/j. atherosclerosis. 2010. 05. 004
93. Erbel C, Wolf A, Lasitschka F, Linden F, Domschke G, Akhavanpoor M, Doesch AO, Katus HA, Gleissner CA. Prevalence of M4 macrophages within human coronary atherosclerotic plaques is associated with features of plaque instability. Int J Cardiol. 2015;186:219-225. doi: 10. 1016/j. ijcard. 2015. 03. 151
94. Robbins CS, Hilgendorf I, Weber GF, et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med. 2013;19:1166-1172. doi: 10. 1038/nm. 3258
95. Tang J, Lobatto ME, Hassing L, et al. Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation. Sci Adv. 2015 Apr;1(3). pii: e1400223
96. Rohm I, Atiskova Y, Drobnik S, Fritzenwanger M, Kretzschmar D, Pistulli R, Zanow J, Krönert T, Mall G, Figulla HR, Yilmaz A. Decreased regulatory T cells in vulnerable atherosclerotic lesions: imbalance between pro-and anti-inflammatory cells in atherosclerosis. Mediators Inflamm. 2015;2015:364710. doi: 10. 1155/2015/364710
97. Bobryshev YV, Lord RS. Co-accumulation of dendritic cells and natural killer T cells within rupture-prone regions in human atherosclerotic plaques. J Histochem Cytochem. 2005;53:781-785. doi: 10. 1369/ jhc. 4B6570. 2005
98. Li Y, To K, Kanellakis P, Hosseini H, Deswaerte V, Tipping P, Smyth MJ, Toh BH, Bobik A, Kyaw T. CD4+ natural killer T cells potently augment aortic root atherosclerosis by perforin-and granzyme B-dependent cytotoxicity. Circ Res. 2015;116:245-254. doi: 10. 1161/ CIRCRESAHA. 116. 304734
99. Godfrey DI, Rossjohn J. New ways to turn on NKT cells. J Exp Med. 2011;208:1121-1125. doi: 10. 1084/jem. 20110983
100. Kim HY, Kim S, Chung DH. FcgammaRIII engagement provides activating signals to NKT cells in antibody-induced joint inflammation. J Clin Invest. 2006;116:2484-2492. doi: 10. 1172/JCI27219
101. Montecucco F, Vuilleumier N, Pagano S, Lenglet S, Bertolotto M, Braunersreuther V, Pelli G, Kovari E, Pane B, Spinella G, Pende A, Palombo D, Dallegri F, Mach F, Roux-Lombard P. Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability. Eur Heart J. 2011;32:412-421. doi: 10. 1093/eurheartj/ ehq521
102. Selathurai A, Deswaerte V, Kanellakis P, Tipping P, Toh BH, Bobik A, Kyaw T. Natural killer (NK) cells augment atherosclerosis by cytotoxic-dependent mechanisms. Cardiovasc Res. 2014;102:128-137. doi: 10. 1093/cvr/cvu016
103. Martínez-Rodríguez JE, Munné-Collado J, Rasal R, Cuadrado E, Roig L, Ois A, Muntasell A, Baro T, Alameda F, Roquer J, López-Botet M. Expansion of the NKG2C+ natural killer-cell subset is associated with high-risk carotid atherosclerotic plaques in seropositive patients for human cytomegalovirus. Arterioscler Thromb Vasc Biol. 2013;33:2653-2659. doi: 10. 1161/ATVBAHA. 113. 302163
104. Kyaw T, Winship A, Tay C, Kanellakis P, Hosseini H, Cao A, Li P, Tipping P, Bobik A, Toh BH. Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice. Circulation. 2013;127:1028-1039. doi: 10. 1161/ CIRCULATIONAHA. 112. 001347
105. Liu AN, Mohammed AZ, Rice WR, Fiedeldey DT, Liebermann JS, Whitsett JA, Braciale TJ, Enelow RI. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand. Am J Respir Cell Mol Biol. 1999;20:849-858. doi: 10. 1165/ ajrcmb. 20. 5. 3585
106. Serbina NV, Lazarevic V, Flynn JL. CD4(+) T cells are required for the development of cytotoxic CD8(+) T cells during Mycobacterium tuberculosis infection. J Immunol. 2001;167:6991-7000
107. Dumitriu IE, Baruah P, Finlayson CJ, Loftus IM, Antunes RF, Lim P, Bunce N, Kaski JC. High levels of costimulatory receptors OX40 and 4-1BB characterize CD4+CD28null T cells in patients with acute coronary syndrome. Circ Res. 2012;110:857-869. doi: 10. 1161/ CIRCRESAHA. 111. 261933
108. Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, Weyand CM. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation. 2000;101:2883-2888
109. Broux B, Markovic-Plese S, Stinissen P, Hellings N. Pathogenic features of CD4+CD28-T cells in immune disorders. Trends Mol Med. 2012;18:446-453. doi: 10. 1016/j. molmed. 2012. 06. 003
110. Baruah P, Lee M, Odutoye T, Williamson P, Hyde N, Kaski JC, Dumitriu IE. Decreased levels of alternative co-stimulatory receptors OX40 and 4-1BB characterise T cells from head and neck cancer patients. Immunobiology. 2012;217:669-675. doi: 10. 1016/j. imbio. 2011. 11. 005
111. Nakajima T, Schulte S, Warrington KJ, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation. 2002;105:570-575
112. White SJ, Newby AC, Johnson TW. Endothelial erosion of plaques as a substrate for coronary thrombosis. Thromb Haemost. 2016;115:509-519. doi: 10. 1160/TH15-09-0765
113. Houtkamp MA, de Boer OJ, van der Loos CM, van der Wal AC, Becker AE. Adventitial infiltrates associated with advanced atherosclerotic plaques: structural organization suggests generation of local humoral immune responses. J Pathol. 2001;193:263-269. doi: 10. 1002/1096-9896(2000)9999:9999::AID-PATH7743. 0. CO;2-N
114. Moreno PR, Purushothaman KR, Fuster V, O'Connor WN. Intimomedial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta: implications for plaque vulnerability. Circulation. 2002;105:2504-2511
115. Kohchi K, Takebayashi S, Hiroki T, Nobuyoshi M. Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy. Circulation. 1985;71:709-716
116. Srikakulapu P, Hu D, Yin C, Mohanta SK, Bontha SV, Peng L, Beer M, Weber C, McNamara CA, Grassia G, Maffia P, Manz RA, Habenicht AJ. Artery tertiary lymphoid organs control multilayered territorialized atherosclerosis B-cell responses in aged ApoE-/-mice. Arterioscler Thromb Vasc Biol. 2016;36:1174-1185. doi: 10. 1161/ATVBAHA. 115. 306983
117. Clement M, Guedj K, Andreata F, et al. Control of the T follicular helper-germinal center B-cell axis by CD8+ regulatory T cells limits atherosclerosis and tertiary lymphoid organ development. Circulation. 2015;131:560-570. doi: 10. 1161/CIRCULATIONAHA. 114. 010988
118. Di Gregoli K, Jenkins N, Salter R, White S, Newby AC, Johnson JL. MicroRNA-24 regulates macrophage behavior and retards atherosclerosis. Arterioscler Thromb Vasc Biol. 2014;34:1990-2000. doi: 10. 1161/ ATVBAHA. 114. 304088
119. Du F, Yu F, Wang Y, Hui Y, Carnevale K, Fu M, Lu H, Fan D. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2014;34:759-767. doi: 10. 1161/ ATVBAHA. 113. 302701
120. Karunakaran D, Richards L, Geoffrion M, Barrette D, Gotfrit RJ, Harper ME, Rayner KJ. Therapeutic inhibition of miR-33 promotes fatty acid oxidation but does not ameliorate metabolic dysfunction in diet-induced obesity. Arterioscler Thromb Vasc Biol. 2015;35:2536-2543. doi: 10. 1161/ATVBAHA. 115. 306404
121. Koulis C, Chen YC, Hausding C, Ahrens I, Kyaw TS, Tay C, Allen T, Jandeleit-Dahm K, Sweet MJ, Akira S, Bobik A, Peter K, Agrotis A. Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2014;34:516-525. doi: 10. 1161/ATVBAHA. 113. 302407
122. Nakashiro S, Matoba T, Umezu R, Koga J, Tokutome M, Katsuki S, Nakano K, Sunagawa K, Egashira K. Pioglitazone-incorporated nanoparticles prevent plaque destabilization and rupture by regulating monocyte/ macrophage differentiation in ApoE-/-mice. Arterioscler Thromb Vasc Biol. 2016;36:491-500. doi: 10. 1161/ATVBAHA. 115. 307057
123. Katsuki S, Matoba T, Nakashiro S, Sato K, Koga J, Nakano K, Nakano Y, Egusa S, Sunagawa K, Egashira K. Nanoparticlemediated delivery of pitavastatin inhibits atherosclerotic plaque destabilization/rupture in mice by regulating the recruitment of inflammatory monocytes. Circulation. 2014;129:896-906. doi: 10. 1161/ CIRCULATIONAHA. 113. 002870
124. Efimov GA, Kruglov AA, Khlopchatnikova ZV, Rozov FN, Mokhonov VV, Rose-John S, Scheller J, Gordon S, Stacey M, Drutskaya MS, Tillib SV, Nedospasov SA. Cell-type-restricted anti-cytokine therapy: TNF inhibition from one pathogenic source. Proc Natl Acad Sci U S A. 2016;113:3006-3011. doi: 10. 1073/pnas. 1520175113
125. Ridker PM. From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection. Circ Res. 2016;118:145-156. doi: 10. 1161/CIRCRESAHA. 115. 306656
126. Eisenhardt SU, Habersberger J, Murphy A, Chen YC, Woollard KJ, Bassler N, Qian H, von Zur Muhlen C, Hagemeyer CE, Ahrens I, Chin-Dusting J, Bobik A, Peter K. Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques. Circ Res. 2009;105:128-137. doi: 10. 1161/ CIRCRESAHA. 108. 190611
127. Thiele JR, Habersberger J, Braig D, Schmidt Y, Goerendt K, Maurer V, Bannasch H, Scheichl A, Woollard KJ, von Dobschütz E, Kolodgie F, Virmani R, Stark GB, Peter K, Eisenhardt SU. Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy. Circulation. 2014;130:35-50. doi: 10. 1161/ CIRCULATIONAHA. 113. 007124